Document Detail


Serum lipoproteins and cancer.
MedLine Citation:
PMID:  18718745     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: In haematological and solid tumours the blood lipoprotein profile has been reported to be altered; while decreased levels of total cholesterol and increased values of triglycerides have been observed. The mechanism and meaning of these changes are, however, not fully understood. The aim of the present study was to determine relationships between cancer progression and serum lipoproteins. METHODS AND RESULTS: We performed a case-control study. We included cancer patients admitted to the 1st Division of Medical Oncology, Businco Hospital of Cagliari, Italy, between 1984 and 1998; 519 patients with any type of solid tumours and 928 healthy controls. We considered total cholesterol (C), high-density lipoprotein (HDL)-C, low-density lipoprotein (LDL)-C, triglycerides and apolipoprotein A-1; other parameters examined were glycaemia, insulinaemia, body mass index (BMI), homeostasis model assessment-estimated insulin resistance (HOMA-IR), C reactive protein (CRP) and tumour necrosis factor-alpha (TNF-alpha). In the cancer group HDL-C and apolipoprotein A-1 were lower (p<0.05) and triglycerides were higher (p<0.05) than in controls; HDL-C (mg/dl) females: 48 vs. 64; males, 40 vs. 52; Apo-A-1 (mg/dl) females: 125 vs. 173; males, 120 vs. 152; triglycerides (mg/dl) females: 133 vs. 96; males, 152 vs. 117. Glucose (mg/dl) was lower in the cancer group (p<0.05); females, 72.3 vs. 80.0; males, 75.7 vs. 78.4. CONCLUSION: Using multivariate analysis we were able to rule out cardiovascular and inflammatory diseases as causes of low HDL-C, and also demonstrate that these alterations can be shown as a specific consequence of the presence of a malignant tumour with a diagnostic and prognostic significance.
Authors:
S Muntoni; L Atzori; R Mereu; G Satta; M D Macis; M Congia; A Tedde; A Desogus; S Muntoni
Related Documents :
11126145 - The emerging role of hdl cholesterol. is it time to focus more energy on raising high-d...
12581545 - Prospective, noninterventional, uncontrolled, open-chart, pharmacoepidemiologic study o...
191215 - Hdl cholesterol and other lipids in coronary heart disease. the cooperative lipoprotein...
11519285 - Lipid profile in the progeny of parents with ischemic heart disease.
1886865 - The effect of minimizing amino acid excesses in broiler diets.
3806255 - Relationship between amino acid composition of diet and plasma cholesterol level in gro...
Publication Detail:
Type:  Journal Article     Date:  2008-08-20
Journal Detail:
Title:  Nutrition, metabolism, and cardiovascular diseases : NMCD     Volume:  19     ISSN:  1590-3729     ISO Abbreviation:  Nutr Metab Cardiovasc Dis     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-03-16     Completed Date:  2009-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111474     Medline TA:  Nutr Metab Cardiovasc Dis     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  218-25     Citation Subset:  IM    
Affiliation:
Department of Toxicology, Oncology and Molecular Pathology Unit, University School of Cagliari, Cagliari, Italy. smuntoni@unica.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Apolipoprotein A-I / blood
Case-Control Studies
Cholesterol, HDL / blood
Disease Progression
Female
Humans
Lipoproteins / blood*
Male
Middle Aged
Neoplasms / blood,  physiopathology*
Retrospective Studies
Sex Factors
Triglycerides / blood
Young Adult
Chemical
Reg. No./Substance:
0/Apolipoprotein A-I; 0/Cholesterol, HDL; 0/Lipoproteins; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of...
Next Document:  Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity ...